Document:

Form of Restricted Stock Grant Agreement

 Exhibit 10.10 
 Arena Pharmaceuticals, Inc. 2009 Long-Term Incentive Plan 
 Restricted Stock Grant Agreement 
 THIS GRANT AGREEMENT (this “Agreement”),
effective as of                                  (the “Grant Date”), is
entered into by and between Arena Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and
                                 (the “Participant”). 
 1. Grant of Restricted Stock. The Company hereby grants to the Participant
                                 restricted shares of common stock of the Company,
par value $0.0001 per share (the “Restricted Stock”). 
 2. Subject to the Plan. This Agreement is subject to the
provisions of the Arena Pharmaceuticals, Inc. 2009 Long-Term Incentive Plan (the “Plan”), and, unless the context requires otherwise, terms used herein shall have the same meaning as in the Plan. In the event of a conflict between the
provisions of the Plan and this Agreement, the Plan shall control. 
 3. Vesting. All of the shares of Restricted Stock shall
initially be unvested. Until shares of Restricted Stock vest, the Participant may not sell, assign, transfer, pledge, or otherwise dispose of such shares. Except as otherwise provided in Sections 5(b) or (c) of this Agreement, provided the
Participant is then any of an Employee, a Consultant or a Director, the Restricted Stock shall become vested on the following dates: 
 Vest Date                    Vested Shares 
 4. Capitalization Adjustments. The number of shares of Restricted Stock shall be equitably and appropriately adjusted as provided in Section 12.2 of the Plan. 
 5. Termination of Employment. 
 (a) Termination of Employment or Service Other Than Due to Death or Disability. In the event the Participant ceases to be in the Company’s continuous service as any of an Employee, a Consultant or a Director for any reason other
than as a result of death or Disability, the shares of Restricted Stock that were not vested at the time the Participant ceases to be in the Company’s continuous service as any of an Employee, a Consultant or a Director shall be immediately
forfeited. 
 (b) Death. Upon the Participant’s death, to the extent the Restricted Stock is not fully vested the shares of
Restricted Stock that would vest on the next anniversary of the Grant Date following the Participant’s death shall become vested based on a fraction, the numerator of which is the number of whole months elapsed since the prior anniversary of
the Grant Date (or, if applicable, the Grant Date) and the denominator of which is 12. 

 (c) Disability. In the event that the Participant
ceases to be in the Company’s continuous service as any of an Employee, a Consultant or a Director by reason of Disability, to the extent the Restricted Stock is not fully vested, the shares of Restricted Stock that would vest on the next
anniversary of the Grant Date following the Participant’s Disability shall become vested based on a fraction, the numerator of which is the number of whole months elapsed since the prior anniversary of the Grant Date (or, if applicable, the
Grant Date) and the denominator of which is 12. For purposes of this Agreement, “Disability” shall mean the Participant’s becoming disabled within the meaning of Section 22(e)(3) of the Code, or as otherwise determined by the
Committee in its discretion. The Committee may require such proof of Disability as the Committee in its sole and absolute discretion deems appropriate and the Committee’s determination as to whether the Participant has incurred a Disability
shall be final and binding on all parties concerned. 
 6. Change in Control; Corporate Transaction. 
 (a) Effect of Change in Control on Restricted Stock. In the event of a Change in Control, the Surviving Corporation or the Parent Corporation, if
applicable, may assume, continue or substitute for the unvested shares of Restricted Stock on substantially the same terms and conditions (which may include replacement with shares of the common stock of the Surviving Corporation or the Parent
Corporation). In the event of a Change in Control, to the extent the Surviving Corporation or the Parent Corporation, if applicable, does not assume, continue or substitute for the unvested shares of Restricted Stock on substantially the same terms
and conditions (which may include replacement with shares of the common stock of the Surviving Corporation or the Parent Corporation), all of such unvested shares of Restricted Stock shall become fully vested immediately prior to the Change in
Control, provided the Participant has been in the Company’s continuous service since the Grant Date as any of an Employee, a Consultant or a Director. In the event of a Change in Control, to the extent the Surviving Corporation or the Parent
Corporation, if applicable, assumes or substitutes for the unvested shares of Restricted Stock on substantially the same terms and conditions (which may include replacement with shares of the common stock of the Surviving Corporation or the Parent
Corporation) and within 24 months following the date of the Change in Control the Participant ceases to be in the Company’s continuous service as either of an Employee or Consultant by reason of (i) an involuntary termination without
Cause, or (ii) a voluntary termination in connection with a Relocation Requirement, all of such shares of Restricted Stock shall become fully vested. 
 For purposes of this Agreement (i) if the Company is the Surviving Corporation or the Parent Corporation, if applicable, it shall be deemed to have assumed the unvested shares of Restricted Stock unless it takes
explicit action to the contrary and (ii) “Relocation Requirement” shall mean a requirement by the Company, the Surviving Corporation or an affiliate thereof that the Participant be based anywhere more than fifty (50) miles from
both the Participant’s primary office location at the time of the Change in Control and the Participant’s principal residence at the time of the Change in Control. For purposes of this Agreement, except as otherwise 

  

 -2- 

 
provided in a written employment or severance agreement between the Participant and the Company or a severance plan of the Company covering the Participant
(including a change in control severance agreement or plan), “Cause” shall mean: a determination by the Committee that the Participant has breached his or her employment or service contract with the Company (or an Affiliate), or has been
engaged in disloyalty to the Company (or an Affiliate), including, without limitation, fraud, embezzlement, theft, commission of a felony or proven dishonesty in the course of his or her employment or service, or has disclosed trade secrets or
confidential information of the Company to persons not entitled to receive such information, or has breached any written noncompetition or nonsolicitation agreement between the Participant and the Company (or an Affiliate) or has engaged in such
other behavior detrimental to the interests of the Company (or an Affiliate) as the Committee determines. 
 (b) Effect of Corporate
Transaction on Restricted Stock. In the event of a Corporate Transaction that is not a Change in Control, any surviving corporation or acquiring corporation (or the surviving or acquiring corporation’s parent company) may assume, continue
or substitute for the unvested shares of Restricted Stock on substantially the same terms and conditions (which may include replacement with shares of the common stock of the surviving corporation, acquiring corporation, or the surviving or
acquiring corporation’s parent company). In the event of a Corporate Transaction that is not a Change in Control, then notwithstanding Section 11 of the Plan and paragraph (a) of this Section, to the extent that the surviving
corporation or acquiring corporation (or its parent company) does not assume, continue or substitute for the unvested shares of Restricted Stock on substantially the same terms and conditions (which may include replacement with shares of the common
stock of the surviving corporation, acquiring corporation, or the surviving or acquiring corporation’s parent company), then all of such unvested shares of Restricted Stock shall become fully vested immediately prior to the Corporate
Transaction if the Participant is then an Employee, a Consultant or a Director. 
 For purposes of this Agreement, “Corporate
Transaction” means (i) the consummation of a merger, consolidation or similar transaction following which the Company is not the surviving corporation; or (ii) the consummation of a merger, consolidation or similar transaction
following which the Company is the surviving corporation but the Shares outstanding immediately preceding the merger, consolidation or similar transaction are converted or exchanged by virtue of the merger, consolidation or similar transaction into
other property, whether in the form of securities, cash or otherwise. Notwithstanding the foregoing, a “Corporate Transaction” shall not include a transaction that is effected exclusively for the purpose of changing the domicile of the
Company. 
 (c) Other Agreement or Plan. The provisions of this Section (including the definition of Cause) shall be superseded by the
specific provisions, if any, of a written employment or severance agreement between the Participant and the Company or a severance plan of the Company covering the Participant, including a change in control severance agreement or plan, to the extent
such a provision in such other agreement or plan provides a greater benefit to the Participant. 
  

 -3- 

 7. Legend. Each certificate issued in respect
of shares of Restricted Stock under the Agreement shall be registered in the Participant’s name and deposited by the Participant, together with a stock power endorsed in blank, with the Company and shall bear the following (or a similar)
legend: 
 “The transferability of this certificate and the shares of stock represented hereby are subject to the terms
and conditions (including forfeiture) contained in an Agreement entered into between the registered owner and Arena Pharmaceuticals, Inc.” 
 When
shares of Restricted Stock become vested, the Company shall redeliver to the Participant (or the Participant’s legal representatives, beneficiaries or heirs) from the shares of Restricted Stock deposited with it the number of shares which have
then vested. The Participant agrees that any resale of shares of Restricted Stock received upon vesting shall be made in compliance with the registration requirements of the Securities Act of 1933 or an applicable exemption therefrom, including
without limitation the exemption provided by Rule 144 promulgated thereunder (or any successor rule). 
 8. Nontransferability.
Except to the extent and under such terms and conditions as determined by the Committee, the Restricted Stock shall be nontransferable otherwise than by will or the laws of descent and distribution. Notwithstanding the foregoing, the Participant
may, by delivering written notice to the Company, in a form provided by or otherwise satisfactory to the Company, designate a third party who, in the event of the Participant’s death, shall thereafter be entitled to receive the vested shares of
Restricted Stock. 
 9. Rights as Stockholder. During the period that shares of Restricted Stock remain unvested, the
Participant shall have all of the rights of a stockholder of the Company with respect to the Restricted Stock, including, but not limited to, the right to receive dividends paid on the shares of Restricted Stock and the right to vote such shares.

 10. Withholding. The Participant agrees to pay to the Company, or to make satisfactory arrangement with the Company for
payment of, any federal, state or local taxes required by law to be withheld in respect of the vesting of the Restricted Stock. The Participant hereby agrees that the Company may withhold from the Participant’s wages or other remuneration the
applicable taxes. At the discretion of the Company, the applicable taxes may be withheld in kind from the Shares otherwise deliverable to the Participant on the vesting of the Restricted Stock. 
 11. Notices. All notices required or permitted under this Agreement shall be in writing and shall be sufficiently made or given if hand
delivered or mailed by registered or certified mail, postage prepaid. Notice by mail shall be deemed delivered on the date on which it is postmarked. 
  

 -4- 

 Notices to the Company should be addressed to: 
 Arena Pharmaceuticals, Inc. 
 6166 Nancy Ridge
Drive 
 San Diego, California 92121 
 Attention: Chief Financial Officer 
 With a copy to: General Counsel 
 Notices to the Participant should be addressed to the Participant at the Participant’s address as it appears on the Company’s records. The
Company or the Participant may by writing to the other party, designate a different address for notices. If the receiving party consents in advance, notice may be transmitted and received via facsimile or via such other electronic transmission
mechanism as may be available to the parties. Such notices shall be deemed delivered when received. 
 12. Headings. The
headings in this Agreement are for reference purposes only and shall not affect the meaning or interpretation of this Agreement. 
 13.
Governing Law. This Agreement shall be governed by, and interpreted in accordance with, the laws of the State of Delaware, other than its conflict of laws principles. 
 14. Agreement Not a Contract. This Agreement (and the grant of Restricted Stock) is not an employment or service contract, and nothing in
this Agreement shall be deemed to create in any way whatsoever any obligation on Participant’s part to continue in the employment or service of the Company as an Employee, a Consultant or a Director, or of the Company or an Affiliate to
continue Participant’s service as an Employee, a Consultant or a Director. 
 15. Entire Agreement; Modification. This
Agreement and the Plan constitute the entire agreement between the parties with respect to the subject matter contained herein and may not be modified, except as provided in the Plan or in a written document signed by each of the parties hereto, and
may be rescinded only by a written agreement signed by both parties. 
 16. Severability. The provisions of this Agreement
shall be deemed severable. If any provision of this Agreement shall be held unlawful or otherwise invalid or unenforceable in whole or in part by a court of competent jurisdiction or by reason of a change in a law or regulation, such provision shall
(i) be deemed limited to the extent that such court of competent jurisdiction deems it lawful, valid and/or enforceable (or, if applicable, to the extent necessary to comply with the change in the law or regulation), and as so limited shall
remain in full force and effect, and (ii) not affect any other provision of this Agreement or part thereof, each of which shall remain in full force and effect. 
  

 -5- 

 IN WITNESS WHEREOF, the parties have executed this
Agreement as of the Grant Date. 
  

			
	ARENA PHARMACEUTICALS, INC.
		
	By:	 	  

	
	  

	Participant

  

 -6-Form of Option Award Notice

 Exhibit 10.1 
 GENESEE & WYOMING INC. 
 AMENDED AND RESTATED 2004 OMNIBUS INCENTIVE PLAN 

FORM OF OPTION AWARD NOTICE 
  

			
	 Grantee:
	  	[Name]
		
	 Type of Award:
	  	[Type]
		
	 Number of Shares:
	  	[Number]
		
	 Exercise Price Per Share:
	  	[Price]
		
	 Date of Grant:
	  	[Date]
		
	 Expiration Date:
	  	[Five Years from the Grant Date]
		
	 Anniversary Date:
	  	[Date of First Grant for the Year of the Option]

 1. Grant of Option. This Award Notice serves to notify you that the Compensation Committee
(the “Committee”) of the Board of Directors of Genesee & Wyoming Inc. (“G&W”) hereby grants to you, under G&W’s Amended and Restated 2004 Omnibus Incentive Plan (the “Plan”), an [Type] stock option
(the “Option”) to purchase, on the terms and conditions set forth in this Award Notice and the Plan, up to the number of shares of G&W’s Class A Common Stock, par value $.01 per share (the “Common Stock”) at the
exercise price per share set forth above. The Plan is incorporated herein by reference and made a part of this Award Notice. A copy of the Plan is available on G&W’s Intranet under Corporate Policies then Human Resources or from
G&W’s Human Resources Department upon request. You should review the terms of this Award Notice and the Plan carefully. The capitalized terms used in this Award Notice that are not defined herein have the meanings as defined in the Plan.

 2. Term. Unless the Option is previously terminated pursuant to the terms of the Plan or this Award Notice, the Option will expire
at the close of business on the Expiration Date. 
 3. Vesting. Subject to the terms set forth in this Award Notice and the
Plan, the Option will vest and become exercisable as follows:  
  

	 	(i)	the Option shall first become exercisable with respect to [Number] Shares on [Anniversary Date Year 1]; 

  

	 	(ii)	the Option shall first become exercisable with respect to an additional [Number] Shares on [Anniversary Date Year 2]; and 

  

	 	(iii)	the Option shall first become exercisable with respect to an additional [Number] Shares on [Anniversary Date Year 3]. 

 4. Exercise. 
 (a) Method of Exercise. To the extent exercisable under Section 3, the Option may be exercised in whole or in part, provided
that the Option may not be exercised for less than one share of Common Stock in any single transaction. The Option shall be exercised by your giving appropriate notice of such exercise to G&W, or its designated agent in accordance with
established procedures, specifying the number of shares of Common Stock that you elect to purchase and the Exercise Price to be paid. Upon determining that compliance with this Award Notice has occurred, including compliance with such reasonable
requirements as G&W may impose pursuant to the Plan or Section 12 of this Award Notice and payment of the Exercise Price, G&W, or its designated agent, shall issue to you a certificate for the shares of Common Stock purchased on the
earliest practicable date (as determined by G&W) thereafter. 
 (b) Payment of Exercise Price. To the extent
permissible under the Plan, the Exercise Price may be paid using any one or any combination of the following methods: 
 (i)
in cash or by check, with such payment accompanying your written exercise notice; 
 [(ii) by delivery of shares of Common
Stock already owned by you, with such shares of Common Stock valued at their Fair Market Value on the date of the Option exercise;] [NOTE: not applicable in Australia or the Netherlands; insert “(ii) RESERVED” if not applicable]

 (iii) subject to any and all limitations imposed by the Committee from time to time (which may not be uniform), a
“cashless exercise,” whereby you would irrevocably instruct a broker or dealer to sell shares of Common Stock on your behalf and deliver cash sale proceeds to G&W, or its designated agent, in payment of the Exercise Price and, if
applicable, direct G&W, or its designated agent, to deliver shares of Common Stock to be issued upon such exercise of this Option directly to such broker or dealer; or 
 (iv) any other method approved or accepted by the Committee in its sole discretion, subject to any and all limitations imposed by the
Committee from time to time (which may not be uniform). 
 [(c) Withholdings. The exercise of the Option is conditioned
upon your making arrangements satisfactory to G&W for the payment to G&W, or its designated agent, of the amount of all taxes required by any governmental authority to be withheld and paid over by G&W to the governmental authority on
account of the exercise. The payment of such withholding taxes to G&W, or its designated agent, may be made by one 

  

 2 

 
or any combination of the following methods: (i) in cash or by check, (ii) by G&W withholding such taxes from any other compensation owed to
you by G&W or any Subsidiary, (iii) pursuant to a cashless exercise program as contemplated in Section 4(b)(iii) above or (iv) any other method approved or accepted by the Committee in its sole discretion, subject, in the case of
Section 4(c)(iii) and this Section 4(c)(iv), to any and all limitations imposed by the Committee from time to time (which may not be uniform) as contemplated in Section 4(b)(iii) and Section 4(b)(iv) above.] [NOTE: this
version of 4(c) is applicable in U.S. and Canada only] 
 [(c) Responsibility for Taxes. Regardless of any action
G&W, its designated agent, or your employer (the “Employer”) takes with respect to any or all income tax, social insurance, payroll tax, payment on account or other tax-related withholding (“Tax-Related Items”), you
acknowledge that the ultimate liability for all Tax-Related Items legally due by you is and remains your responsibility and that G&W and/or the Employer (1) make no representations or undertakings regarding the treatment of any Tax-Related
Items in connection with any aspect of the Option grant, including the grant, vesting or exercise of the Option, the subsequent sale of shares of Common Stock acquired pursuant to such exercise and the receipt of any dividends; and (2) do not
commit to structure the terms of the grant or any aspect of the Option to reduce or eliminate your liability for Tax-Related Items. 
 Prior
to exercise of the Option, you shall pay or make adequate arrangements satisfactory to G&W and/or the Employer to satisfy all withholding and payment on account of obligations of G&W and/or the Employer. In this regard, you authorize G&W
and/or the Employer to withhold all applicable Tax-Related Items legally payable by you from your wages or other cash compensation paid to you by G&W and/or the Employer or from proceeds of the sale of shares of Common Stock. Alternatively, or
in addition, if permissible under local law, G&W, or its designated agent, may sell or arrange for the sale of shares of Common Stock that you acquire to meet the withholding obligation for Tax-Related Items. Finally, you shall pay to G&W,
its designated agent, or the Employer any amount of Tax-Related Items that G&W or the Employer may be required to withhold as a result of your participation in the Plan or your purchase of shares of Common Stock that cannot be satisfied by the
means previously described. G&W, or its designated agent, may refuse to honor the exercise and refuse to deliver the shares of Common Stock if you fail to comply with your obligations in connection with the Tax-Related Items as described in this
section. 
 The payment of such withholding taxes to G&W may also be made pursuant to any method approved or accepted by the
Committee in its sole discretion, subject to any and all limitations imposed by the Committee from time to time (which may not be uniform) as contemplated in Section 4(b)(iii) and 4(b)(iv) above.] [NOTE: this version of 4(c) is applicable in
Australia and the Netherlands only] 
 5. Effect of Death. In the event of your death prior to the complete exercise of the
Option, the remaining portion of the Option may be exercised in whole or in part, subject to all of the conditions on exercise imposed by the Plan and this Award Notice, within one year after the date of your death, but only: (i) by the
beneficiary designated 

  

 3 

 
on your beneficiary designation form filed with G&W, or in the absence of same, by your estate or by or on behalf of the person or persons to whom the
Option passes under your will or the laws of descent and distribution, (ii) to the extent that the Option was vested and exercisable on the date of your death, and (iii) prior to the close of business on the Expiration Date of the Option.

 6. Effect of Disability. In the event of your “Disability” prior to the complete exercise of the Option, the remaining
portion of the Option may be exercised in whole or in part, subject to all of the conditions on exercise imposed by the Plan and this Award Notice, within one year after the date of your Disability, but only: (i) to the extent that the Option
was vested and exercisable on the date of your Disability, and (ii) prior to the close of business on the Expiration Date of the Option. The term “Disability” means you are permanently and totally disabled within the meaning of
Section 22(e)(3) of the Code. 
 7. Effect of Other Termination. 
 (a) With “Cause.” Upon your termination by G&W for Cause prior to the complete exercise of the Option, the remaining
portion of the Option, whether or not then exercisable, shall be forfeited as of the date of such termination and no longer exercisable on or after such date of termination. 
 (b) Without “Cause.” Upon your termination for a reason other than death, Disability or Cause prior to the complete
exercise of the Option, the remaining portion of the Option may be exercised in whole or in part, subject to all of the conditions on exercise imposed by the Plan and this Award Notice, within three months after the date of such termination, but
only: (i) to the extent that the Option was vested and exercisable on the date of such termination, and (ii) prior to the Expiration Date of the Option. 
 (c) The term “Cause” means (i) your willful and continued failure to substantially perform your duties with G&W or a
Subsidiary after written warnings identifying the lack of substantial performance are delivered to you to specifically identify the manner in which G&W or a Subsidiary believes that you have not substantially performed your duties,
(ii) your willful engaging in illegal conduct which is materially and demonstrably injurious to G&W or any Subsidiary, (iii) your commission of a felony, (iv) your material breach of a fiduciary duty owed by you to G&W or any
Subsidiary, (v) your intentional unauthorized disclosure to any person of confidential information or trade secrets of a material nature relating to the business of G&W or any Subsidiary, or (vi) your engaging in any conduct that
G&W’s or a Subsidiary’s written rules, regulations or policies specify as constituting grounds for discharge. 
 [(d) In the event of termination of your employment (whether or not in breach of local labor laws), your right to receive an Option and vest in an Option under the Plan, if any, will terminate effective as of the date that you are no longer
actively employed and will not be extended by any notice period mandated under local law (e.g., active employment would not include a period of “garden leave” or similar period 

  

 4 

 
pursuant to local law); furthermore, in the event of termination of employment (whether or not in breach of local labor laws), your right to exercise the
Option after termination of employment, if any, will be measured by the date of termination of your active employment and will not be extended by any notice period mandated under local law; the Committee shall have the exclusive discretion to
determine when you are no longer actively employed for purposes of your Option grant.] [NOTE: this provision 7(d) is applicable in Australia and the Netherlands only] 
 [8. Notice of Disposition of Shares. You hereby agree that you shall promptly notify G&W of the disposition of any of the shares of
Common Stock acquired upon exercise of the Option, including a disposition by sale, exchange, gift or transfer of legal title, if such disposition occurs within two years from the Date of Grant or within one year from the date that you exercise the
Option and acquire such shares of Common Stock.] [NOTE: this provision 8 is applicable in U.S. only; if not applicable insert “8. RESERVED”] 
 9. Nonassignability. The Option may not be sold, alienated, transferred, assigned, encumbered or pledged in any way prior to the vesting of the Option, whether by operation of law or otherwise, except by will
or the laws of descent and distribution. Except as otherwise provided by Section 5 of this Award Notice, the Option is only exercisable by you during your lifetime. After exercising the Option, the sale or other transfer of the shares of Common
Stock shall be subject to applicable laws and regulations under the Exchange Act. 
 10. Limitation of Rights. You will not have any
rights as a stockholder with respect to the shares of Common Stock covered by the Option until you become the holder of record of such shares by exercising the Option. Neither the Plan, the granting of the Option nor this Award Notice gives you any
right to remain in the employment of G&W or any Subsidiary. 
 11. Rights of G&W and Subsidiaries. This Award Notice does not
affect the right of G&W or any Subsidiary to take any corporate action whatsoever, including without limitation its right to recapitalize, reorganize or make other changes in its capital structure or business, merge or consolidate, issue bonds,
notes, shares of Common Stock or other securities, including preferred stock, or options therefor, dissolve or liquidate, or sell or transfer any part of its assets or business. 
 12. Restrictions on Issuance of Shares. If at any time G&W determines that the listing, registration or qualification of the shares covered by
the Option upon any securities exchange or under any federal, state or local law, or the approval of any governmental agency, is necessary or advisable as a condition to the exercise of the Option, the Option may not be exercised in whole or in part
unless and until such listing, registration, qualification or approval shall have been effected or obtained free of any conditions not acceptable to G&W. 
  

 5 

 13. Plan Controls. The Option is subject to all of the provisions of the Plan, which is hereby
incorporated by reference, and is further subject to all the interpretations, amendments, rules and regulations that may from time to time be promulgated and adopted by the Committee pursuant to the Plan. In the event of any conflict among the
provisions of the Plan and this Award Notice, the provisions of the Plan will be controlling and determinative. 
 14. Amendment.
Except as otherwise provided by the Plan, G&W may only alter, amend or terminate the Option with your consent. 
 15. Governing
Law. This Option grant and Award Notice shall be governed by and construed in accordance with the laws of the State of New York, except as superseded by applicable federal law, without giving effect to its conflicts of law provisions.

 16. Notices. All notices and other communications to G&W, or its designated agent, required or permitted under this Award
Notice shall be written, and shall be either delivered personally or sent by registered or certified first-class mail, postage prepaid and return receipt requested, by facsimile, or electronically. If such notice or other communication is to G&W
then it should be addressed to G&W’s office at 1200-C Scottsville Road, Suite 200, Rochester, New York 14624, Attention: Equity Plan Administrator; Telephone: (585) 328-8601; Facsimile: (585) 328-8622; Email:
EquityPlanAdmin@gwrr.com. If such notice or other communication is to G&W’s designated agent, then it should be addressed and sent in accordance with established procedures. Each such notice and other communication delivered
personally shall be deemed to have been given when received. Each such notice and other communication delivered by United States mail shall be deemed to have been given when it is received, and each such notice and other communication delivered by
telex, telecopier or electronically shall be deemed to have been given when it is so transmitted and the appropriate answerback is received. 
 17. Language. If you have received this Award Notice or any other document related to the Plan in a language other than English and if the translated version bears a meaning that is different from that of the English version, the
English version will control, to the extent permitted by law. 
 18. Data Privacy. You hereby explicitly and unambiguously
consent to the collection, use and transfer, in electronic or other form, of your personal data as described in this document by and among, as applicable, the Employer, and G&W and its Subsidiaries and affiliates for the exclusive purpose of
implementing, administering and managing your participation in the Plan, to the extent permitted by law. 
 You understand that G&W and
the Employer may hold certain personal information about you, including, but not limited to, your name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, any
shares of stock or directorships held in G&W, details of all options or any other entitlement to shares of stock awarded, canceled, exercised, vested, unvested or outstanding in your favor, for the purpose of implementing, administering and
managing the Plan (“Data”). You understand that Data may be 

  

 6 

 
transferred to any third parties assisting in the implementation, administration and management of the Plan, that these recipients may be located in your
country or elsewhere, and that the recipient’s country may have different data privacy laws and protections than your country. You understand that you may request a list with the names and addresses of any potential recipients of the Data by
contacting your local human resources representative. You authorize the recipients to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole purpose of implementing, administering and managing your
participation in the Plan, including any requisite transfer of such Data as may be required to a broker or other third party with whom you may elect to deposit any shares of stock acquired upon exercise of the Option, to the extent permitted by
law. You understand that Data will be held only as long as is necessary to implement, administer and manage your participation in the Plan. You understand that you may, at any time, view Data, request additional information about the storage
and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing your local human resources representative. You understand, however, that refusing or
withdrawing your consent may affect your ability to participate in the Plan. For more information on the consequences of your refusal to consent or withdrawal of consent, you understand that you may contact your local human resources representative.

 19. Electronic Delivery. G&W may, in its sole discretion, decide to deliver any documents related to the Option granted under
the Plan (or related to future options that may be granted under the Plan) by electronic means or to request your consent to participate in the Plan by electronic means. You hereby consent to receive such documents by electronic delivery and, if
requested, hereby agree to participate in the Plan through an on-line or electronic system established and maintained by G&W or another third party designated by G&W. 
 20. Severability. The provisions of this Award Notice are severable and if any one or more provisions are determined to be illegal or otherwise
unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable. 
 [xx. Nature
of Grant. In accepting the grant, you acknowledge that: 
 (a) the Plan is established voluntarily by G&W, it is
discretionary in nature and it may be modified, amended, suspended or terminated by G&W at any time, unless otherwise provided in the Plan and this Award Notice; 
 (b) the grant of the Option is voluntary and occasional and does not create any contractual or other right to receive future grants of
options, or benefits in lieu of options, even if options have been granted repeatedly in the past; 
 (c) all decisions with
respect to future option grants, if any, will be at the sole discretion of G&W; 
  

 7 

 (d) your participation in the Plan shall not create a right to further employment with
the Employer and shall not interfere with the ability of the Employer to terminate your employment relationship at any time with or without cause; 
 (e) you are voluntarily participating in the Plan; 
 (f) the Option is an extraordinary item
that does not constitute compensation of any kind for services of any kind rendered to G&W or the Employer, and which is outside the scope of your employment contract, if any; 
 (g) the Option is not part of normal or expected compensation or salary for any purposes, including, but not limited to, calculating any
severance, resignation, termination, redundancy, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments and in no event should be considered as compensation for, or relating in any way to, past
services for G&W or the Employer; 
 (h) in the event that you are not an employee of G&W, the Option grant will not
be interpreted to form an employment contract or relationship with G&W; and furthermore, the Option grant will not be interpreted to form an employment contract with the Employer or any Subsidiary or affiliate of G&W; 
 (i) the future value of the underlying shares of Common Stock is unknown and cannot be predicted with certainty; 
 (j) if the underlying shares of Common Stock do not increase in value, the Option will have no value; 
 (k) if you exercise your Option and obtain shares of Common Stock, the value of those shares of Common Stock acquired upon exercise may
increase or decrease in value, even below the exercise price; and 
 (l) in consideration of the grant of the Option, no claim
or entitlement to compensation or damages shall arise from termination of the Option or diminution in value of the Option or shares of Common Stock purchased through exercise of the Option resulting from termination of your employment by G&W or
the Employer (for any reason whatsoever and whether or not in breach of local labor laws) and you irrevocably release G&W and the Employer from any such claim that may arise; if, notwithstanding the foregoing, any such claim is found by a court
of competent jurisdiction to have arisen, then, by signing this Award Notice, you shall be deemed irrevocably to have waived your entitlement to pursue such claim.] [NOTE: this section is only applicable in Australia and the Netherlands]

 [xy. Effect of Breach of Certain Covenants. 
 (a) In General. If you engage in the conduct described in subsection (c) of this Section [xy], then, unless the Committee
determines otherwise: (i) you immediately forfeit, effective as of the date you engage in such conduct, the unexercised 

  

 8 

 
portion of the Option; and (ii) you must pay to G&W the amount of any gain realized or payment received as a result of the exercise of the Option
within the six-month period immediately preceding the date you engage in such conduct. 
 (b) Set-Off. By accepting the
Option, you consent to a deduction from any amounts G&W or any Subsidiary owes you from time to time (including, but not limited to, amounts owed to you as wages or other compensation, fringe benefits, or vacation pay), to the extent of the
amount that you owe G&W under subsection (a) of this Section [xy]. G&W may elect to make any set-off in whole or in part. If G&W does not recover by means of a set-off the full amount that you owe G&W, you shall immediately pay
the unpaid balance to G&W. 
 (c) Conduct. You hereby agree that you will not, without the written consent of
G&W, either during your employment by or service to G&W or any Subsidiary or thereafter, disclose to anyone or make use of any confidential information which you acquired during your employment or service relating to any of the business of
G&W or any Subsidiary, except as such disclosure or use may be required in connection with your work as an employee or consultant of G&W or any Subsidiary. During your employment by or service to G&W or any Subsidiary, and for a period
of six months after the termination of such employment or service, you will not, either as principal, agent, consultant, employee, stockholder or otherwise, engage in any work or other activity in direct competition with G&W or any Subsidiary.
(For purposes of this Section [xy], you shall not be deemed a stockholder of any company subject to the periodic and other reporting requirements of the Exchange Act, if your record and beneficial ownership of any such company amount to not more
than five percent of the outstanding capital stock of any such company.) The non-competition covenant of this Section [xy] applies separately in the United States and in other countries. Your breach of the covenant of this subsection (c) shall
result in the consequences described in this Section [xy].] [NOTE: this section is only applicable to some Grantees, including Executive Officers] 
 [xz. Effect of Change in Control. 
 (a) Upon the occurrence of a “Change in
Control” of G&W, the unvested portion of the Option shall immediately vest as of the date of the occurrence of such event. 
 (b) The term “Change in Control” shall be deemed to have occurred when: 
 (i) Any “person” as
defined in Section 3(a)(9) of the Exchange Act, and as used in Section 13(d) and 14(d) thereof, including a “group” as defined in Section 13(d) of the Exchange Act (but excluding G&W and any Subsidiary and any employee
benefit plan sponsored or maintained by G&W or any Subsidiary (including any trustee of such plan acting as trustee)), directly or indirectly, becomes the “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act), of
securities of G&W 

  

 9 

 
representing 35% or more of the combined voting power of G&W’s then outstanding securities (other than indirectly as a result of G&W’s
redemption of its securities); provided, however, that in no event shall a Change in Control be deemed to have occurred under this Section [xz](b)(i) so long as (x) the combined voting power of shares beneficially owned by
(A) G&W’s executive officers (as defined in Rule 16a-1(f) under the Exchange Act) then in office (the “Executive Officer Shares”), (B) Mortimer B. Fuller and/or Sue Fuller and their lineal descendents (the “Founder
Shares”), and (C) the shares beneficially owned by any other members of a “group” that includes the Founder Shares and/or a majority of the Executive Officer shares, exceeds 35% of the combined voting power of G&W’s
current outstanding securities and remains the person or group with beneficial ownership of the largest percentage of combined voting power of G&W’s outstanding securities and (y) G&W remains subject to the reporting requirements
of the Exchange Act; or 
 (ii) The consummation of any merger or other business combination of G&W, a sale of 51% or more
of G&W’s assets, liquidation or dissolution of G&W or a combination of the foregoing transactions (the “Transactions”) other than a Transaction immediately following which either (x) the shareholders of G&W and any
trustee or fiduciary of any G&W employee benefit plan immediately prior to the Transaction own at least 51% of the voting power, directly or indirectly, of (A) the surviving corporation in any such merger or other business combination;
(B) the purchaser of or successor to G&W’s assets; (C) both the surviving corporation and the purchaser in the event of any combination of Transactions; or (D) the parent company owning 100% of such surviving corporation,
purchaser or both the surviving corporation and the purchaser, as the case may be ((A), (B), (C) or (D), as applicable, the “Surviving Entity”) or (y) the Incumbent Directors, as defined below, shall continue to serve as a
majority of the board of directors of the Surviving Entity without an agreement or understanding that such Incumbent Directors will later surrender such majority; or 
 (iii) Within any twelve-month period, the persons who were directors immediately before the beginning of such period (the “Incumbent
Directors”) shall cease (for any reason other than death) to constitute at least a majority of the Board or the board of directors of any successor to G&W, including any Surviving Entity. For this purpose, any director who was not a
director at the beginning of such period shall be deemed to be an Incumbent Director if such director was elected to the Board by, or on the recommendation of, or with the approval of, at least two-thirds of the directors who then qualified as
Incumbent Directors (so long as such director was not nominated by a person who commenced or threatened to commence an election contest or proxy solicitation by or on behalf of a person (other than the Board) or who has entered into an agreement to
effect a Change in Control or expressed an intention to cause such a Change in Control).] [NOTE: this section is only applicable to some Grantees, including Executive Officers] 
  

 10 

 ACKNOWLEDGEMENT 
 The undersigned acknowledges receipt of, and understands and agrees to be bound by, this Award Notice and the Plan. The undersigned further acknowledges that this Award Notice and the Plan set forth the entire
understanding between him and G&W regarding the [Type] stock options granted by this Award Notice and that this Award Notice and the Plan supersede all prior oral and written agreements on that subject. 
 Dated:
                             
  

	
	  
	                [Name]
	
	Genesee & Wyoming Inc. By:
	
	  
	                Matthew C. Brush
	    Chief Human Resource Officer

  

 11 

 [NOTE: only applicable in the Netherlands] 
 ADDENDUM TO NON-QUALIFIED OPTIONS AWARD NOTICE 
 THE PARTIES 
  

	(1)	GENESEE & WYOMING INC, a company incorporated under the laws of the State of Delaware, the United States, duly represented by Matthew C. Brush, hereafter referred to
as G&W 

 And 
  

	(2)	[Name], residing at [Address], hereafter referred to as the Beneficiary 

 The parties referred to under (1) and (2) above are hereafter together referred to as the Parties. 
 WHEREAS 
  

	(A)	The Beneficiary is managing director of Rotterdam Rail Feeding B.V. (“RRF”) and Beneficiary has entered into an employment contract with RRF on [Date];

  

	(B)	G&W has acquired the entire share capital of RRF on [Date]; 

  

	(C)	G&W and the Beneficiary have agreed on an option grant as described in the letter dated [Date]; 

  

	(D)	In connection with the letter referred to under (C) above, the Parties enter into an Award Notice (the “Award Notice”); and 

  

	(E)	For the purpose of compliance of the Award Notice with the provisions of Dutch law (if applicable), the terms and conditions of this Addendum shall apply in deviation of, or in
addition to certain terms and conditions of the Award Notice. 

 HAVE AGREED ON THE FOLLOWING 
  

	1.	DEFINITIONS 

 Except as provided otherwise in this
Addendum, the definitions of the Award Notice shall apply to this Addendum. 
  

	2.	DISABILITY 

 Clause 7 of the Award Notice shall, in
addition to the meaning provided in that Clause, also apply in the circumstance that the Beneficiary is permanently ill and that, as a result thereof, the employment contract between the Beneficiary and RRF is terminated, in compliance with Dutch
law. 
  

 12 

	3.	[NON COMPETITION 

 Clause [xy](c) of the Award
Notice provides for a non-competition covenant to which the Beneficiary shall be bound for a period of six months following the termination of the Beneficiary’s employment contract with RRF. In deviation of Clause [xy](c) of the Award Notice,
the non-competition covenant is limited solely to the territory of Europe.] [NOTE: this section 3 is only applicable to some Grantees; insert “3. RESERVED” if not applicable] 
  

	4.	DATA PRIVACY 

  

	4.1	In deviation of Clause 18 of the Award Notice, the following shall apply. The Parties acknowledge that all personal data which are necessary for the performance of the contract
provided in the Award Notice shall be collected, used and/or transferred to G&W. The personal data shall be processed for the exclusive purpose of implementing, administering and managing the Beneficiary’s participation in the Plan.
Furthermore, Parties acknowledge that RRF shall be the controller in the meaning of the Dutch Data Protection Act. To the extent necessary, the Beneficiary explicitly agrees with the processing of his personal data as referred to in this Clause 4 of
the Addendum, and specifically with the transfer of the Beneficiary’s personal data to G&W in the United States. 

  

	4.2	The personal data to be processed shall include: the Beneficiary’s name, home address, e-mail address, salary, job title, any shares of stock or directorships held in G&W,
details of all options or any other entitlement to shares of stock awarded, cancelled, exercised, vested, unvested or outstanding in favour of the Beneficiary, necessary for the performance of the Award Notice. Upon the vesting of the options,
additional information may be required regarding bank or brokerage account(s) held by the Beneficiary. In case of death of the Beneficiary, the personal data mentioned in this Clause 4.2 shall also be required from the Beneficiary’s inheritors.

  

	5.	AWARD NOTICE 

 Unless described otherwise in this
Addendum, the terms and conditions of the Award Notice shall be fully valid and binding between the Parties. 
  

	6.	GOVERNING LAW 

  

	6.1	This Addendum shall be governed by the laws of the Netherlands. 

  

	6.2	The competent court of Rotterdam has exclusive jurisdiction to settle any dispute arising out of or in connection with this Addendum. 

  

 13 

 SIGNATORIES 
 Thus
agreed upon and executed in duplicate in                              on
                    . 
  

	
	  
	
	[Name]
	
	Genesee & Wyoming Inc. By:
	
	  
	                Matthew C. Brush
	    Chief Human Resource Officer

  

 14

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00161-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00161-of-00352.parquet"}]]